Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Scott Binder, M.D.
Scott Binder, M.D.


Anatomic pathology and clinical pathology

General Information:



Clinical Professor and Senior Vice Chair, Department of Pathology and Laboratory Medicine
Director, Pathology Clinical Services
Chief of Dermatopathology
Member, JCCC Signal Transduction and Therapeutics Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center


Dermatopathology, Scripps Clinic & Research, 1990 - 1991
Anatomic and Clinical Pathology, UCLA School of Medicine, 1986 - 1990
Anatomic and Clinical Pathology, UCLA School of Medicine, 1985 - 1986
Medical Degree:
M.D., Chicago Medical School, 1985


Board Certification(s):
Dermatopathology, American Board of Pathology, 1991
Anatomic Pathology and Clinical Pathology, American Board of Pathology, 1990

Contact Information:

(310) 319-4515 Information and referral
(310) 206-6594

Scientific Interest(s):

Dr. Scott Binder's primary research interests are melanoma and non-melanoma skin cancer.

Selected Cancer-Related Publications:

Su A, Dry SM, Binder SW, Said J, Shintaku P, Sarantopoulos GP. Malignant Melanoma With Neural Differentiation: An Exceptional Case Report and Brief Review of the Pertinent Literature. Am J Dermatopathol. 2013 Jun 18. [Epub ahead of print]

Sarantopoulos GP, Palla B, Said J, Kinney MC, Swerdlow SM, Willemze R, Binder SW. Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol. 2013 Apr;139(4):536-51. doi: 10.1309/AJCPX4BXTP2QBRKO.

Lugassy C, Wadehra M, Li X, Corselli M, Akhavan D, Binder SW, Peault B, Cochran AJ, Mischel PS, Kleinman HK, Barnhill RL. Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface. Cancer Microenviron. 2013 Apr;6(1):19-29. doi: 10.1007/s12307-012-0128-5. Epub 2012 Dec 29.

Kulkarni RP, Plaisier S, Ra SH, Li X, Lee DJ, Hillman JD, Binder SW. Genetic profiling of BRAF inhibitor-induced keratoacanthomas reveals no induction of MAP kinase pathway expression. J Invest Dermatol. 2013 Mar;133(3):830-3. doi: 10.1038/jid.2012.353. Epub 2012 Sep 27.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases. Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32. Epub 2012 Mar 9.